Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Liang, Chih Ming ^a   Lee, Jyong Hong ^a   Kuo, Yuan Hung ^a   Wu, Keng Liang ^a,b   Chiu, Yi Chun ^a,b   Chou, Yeh Pin ^a,b   Hu, Ming Luen ^a   Tai, Wei Chen ^a,b   Chiu, King Wah ^a   Hu, Tsung Hui ^a,b   Chuah, Seng Kee ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Endoscopic hemostasis; Intravenous proton pump inhibitors; Peptic ulcer bleeding; Rebleeding; Rockall scores

Indexed keywords

CREATININE; HEMOGLOBIN; PANTOPRAZOLE; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CASE CONTROL STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEMOSTASIS; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER BLEEDING; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; TREATMENT DURATION; TREATMENT RESPONSE; BLOOD; CHI SQUARE DISTRIBUTION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECURRENT DISEASE;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CREATININE; FEMALE; HEMOGLOBINS; HEMOSTASIS, ENDOSCOPIC; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIC ULCER HEMORRHAGE; PROTON PUMP INHIBITORS; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 84858970668     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-28     Document Type: Article

References (38)

1. Blatchford O, Davidson LA, Murray WR, Blatchford M, Pell J. Acute upper gastrointestinal haemorrhage in west of Scotland: case ascertainment study. BMJ 1997, 315:510-514. 10.1136/bmj.315.7107.510, 2127364, 9329304.
2. Jiranek GC, Kozarek RA. A cost-effective approach to the patient with peptic ulcer bleeding. Surg Clin North Am 1996, 76:83-103. 10.1016/S0039-6109(05)70424-2, 8629205.
3. Lin HJ, Wang K, Perng CL, Chua RT, Lee FY, Lee CH, Lee SD. Octreotide and heater probe thermocoagulation for arrest of peptic ulcer hemorrhage. A prospective, randomized, controlled trial. J Clin Gastroenterol 1995, 21:95-98. 10.1097/00004836-199509000-00006, 8583094.
4. Laine L. Multipolar electrocoagulation versus injection therapy in the treatment of bleeding peptic ulcers. A prospective, randomized trial. Gastroenterology 1990, 99:1303-1306.
5. Green FW, Kaplan MM, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978, 74:38-43.
6. Patchett SE, O'Donoghue DP. Pharmacological manipulation of gastric juice: thrombelastographic assessment and implications for treatment of gastrointestinal haemorrhage. Gut 1995, 36:358-362. 10.1136/gut.36.3.358, 1382445, 7535282.
7. Chaimoff C, Creter D, Djaldetti M. The effect of pH on platelet and coagulation factor activities. Am J Surg 1978, 136:257-259. 10.1016/0002-9610(78)90241-6, 28678.
8. Netzer P, Gaia C, Sandoz M, Huluk T, Gut A, Halter F, Hüsler J, Inauen W. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours. Am J Gastroenterol 1999, 94:351-357.
9. Hung WK, Li VK, Chung CK, Ying MW, Loo CK, Liu CK, Lam BY, Chan MC. Randomized trial comparing pantoprazole infusion, bolus and no treatment on gastric pH and recurrent bleeding in peptic ulcers. ANZ J Surg 2007, 77:677-681. 10.1111/j.1445-2197.2007.04185.x, 17635283.
10. Barkun AN, Bardou M, Kuipers EJ, Sung J, Hunt RH, Martel M, Sinclair P, . International Consensus Upper Gastrointestinal Bleeding Conference Group International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2010, 152:101-113. International Consensus Upper Gastrointestinal Bleeding Conference Group.
11. Sung JJ, Chan FK, Chen M, Ching JY, Ho KY, Kachintorn U, Kim N, Lau JY, Menon J, Rani AA, Reddy N, Sollano J, Sugano K, Tsoi KK, Wu CY, Yeomans N, Vakil N, Goh KL. Asia-Pacific Working Group. Asia-Pacific Working Group consensus on non-variceal upper gastrointestinal bleeding. Gut 2011, 60:1170-1177. 10.1136/gut.2010.230292, 21471571.
12. Andriulli A, Loperfido S, Focareta R, Leo P, Fornari F, Garripoli A, Tonti P, Peyre S, Spadaccini A, Marmo R, Merla A, Caroli A, Forte GB, Belmonte A, Aragona G, Imperiali G, Forte F, Monica F, Caruso N, Perri F. High- versus low-dose proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding: a multicentre, randomized study. Am J Gastroenterol 2008, 103:3011-3118. 10.1111/j.1572-0241.2008.02149.x, 19086953.
13. Cheng HC, Kao AW, Chuang CH, Sheu BS. The efficacy of high- and low-dose intravenous omeprazole in preventing rebleeding for patients with bleeding peptic ulcers and comorbid illnesses. Dig Dis Sci 2005, 50:1194-1201. 10.1007/s10620-005-2759-6, 16047459.
14. Simon-Rudler M, Massard J, Bernard-Chabert B, DIM V, Ratziu V, Poynard T, Thabut D. Continuous infusion of high-dose omeprazole is more effective than standard-dose omeprazole in patients with high-risk peptic ulcer bleeding: a retrospective study. Aliment Pharmacol Ther 2007, 25:49-54.
15. Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996, 38:316-321. 10.1136/gut.38.3.316, 1383057, 8675081.
16. Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet 1974, 2:394-397.
17. Consensus conference Therapeutic endoscopy and bleeding ulcers. JAMA 1989, 262:1369-1372. Consensus conference.
18. Church NI, Dallal HJ, Masson J, Mowat NA, Johnston DA, Radin E, Turner M, Fullarton G, Prescott RJ, Palmer KR. Validity of the Rockall scoring system after endoscopic therapy for bleeding peptic ulcer: a prospective cohort study. Gastrointest Endosc 2006, 63:606-612. 10.1016/j.gie.2005.06.042, 16564860.
19. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005, 67:2089-2100. 10.1111/j.1523-1755.2005.00365.x, 15882252.
20. Xu HW, Wang JH, Tsai MS, Wu KL, Chiou SS, Changchien CS, Hu TH, Lu SN, Chuah SK. The effects of cefazolin on cirrhotic patients with acute variceal hemorrhage after endoscopic interventions. Surg Endosc 2011, 25:2911-2918. 10.1007/s00464-011-1642-0, 21424196.
21. Yuksel I, Ataseven H, Koklu S, Ertugrul I, Basar O, Odemiş B, Ibiş M, Saşmaz N, Sahin B. Intermittent versus continuous pantoprazole infusion in peptic ulcer bleeding: a prospective randomized study. Digestion 2008, 78:39-43. 10.1159/000158227, 18824852.
22. Wang CH, Ma MH, Chou HC, Yen ZS, Yang CW, Fang CC, Chen SC. High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: a systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 2010, 170:751-758. 10.1001/archinternmed.2010.100, 20458081.
23. Wu LC, Cao YF, Huang JH, Liao C, Gao F. High-dose vs low-dose proton pump inhibitors for upper gastrointestinal bleeding: a meta-analysis. World J Gastroenterol 2010, 16:2558-2565. 10.3748/wjg.v16.i20.2558, 2877188, 20503458.
24. Songür Y, Balkarli A, Acartürk G, Senol A. Comparison of infusion or low-dose proton pump inhibitor treatments in upper gastrointestinal system bleeding. Eur J Int Med 2011, 22:200-204.
25. Chen CC, Lee JY, Fang YJ, Hsu SJ, Han ML, Tseng PH, Liou JM, Hu FC, Lin TL, Wu MS, Wang HP, Lin JT. Randomised clinical trial: high-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers. Aliment Pharmacol Ther 2012, 35:894-903. doi:10.1111/j.1365-2036.2012.05047.x.
26. Netzer P, Gaia C, Sandoz M, Huluk T, Gut A, Halter F, Hüsler J, Inauen W. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours. Am J Gastroenterol 1999, 94:351-357.
27. Javid G, Zargar SA, U-Saif R, Khan BA, Yatoo GN, Shah AH, Gulzar GM, Sodhi JS, Khan MA. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer. J Gastroenterol Hepatol 2009, 24:1236-1243. 10.1111/j.1440-1746.2009.05900.x, 19682194.
28. Laine L, Shah A, Bemanian S. Intragastric pH with oral vs intravenous bolus plus infusion proton-pump inhibitor therapy in patients with bleeding ulcers. Gastroenterology 2008, 134:1836-1841. 10.1053/j.gastro.2008.03.006, 18423628.
29. Laterre PF, Horsmans Y. Intravenous omeprazole in critically ill patients: a randomized, crossover study comparing 40 with 80 mg plus 8 mg/hour on intragastric pH. Crit Care Med 2001, 29:1931-1935. 10.1097/00003246-200110000-00014, 11588454.
30. Kiilerich S, Rannem T, Elsborg L. Effect of intravenous infusion of omeprazole and ranitidine on twenty-four-hour intragastric pH in patients with a history of duodenal ulcer. Digestion 1995, l56:25-30.
31. Choi KD, Kim N, Jang IJ, Park YS, Cho JY, Kim JR, Shin JM, Jung HC, Song IS. Optimal dose of intravenous pantoprazole in patients with peptic ulcer bleeding requiring endoscopic hemostasis in Korea. J Gastroenterol Hepatol 2009, 24:1617-1624. 10.1111/j.1440-1746.2009.05939.x, 19686407.
32. Dokas SM, Lazaraki GI, Kontoninas Z. Bolus intravenous omeprazole b.i.d. vs. continuous intravenous omeprazole infusion combined with endoscopic hemostasis in the treatment of peptic ulcer bleeding. Preliminary results [abstract]. Gut 2004, 53(supplement 6):A290.
33. Cheng HC, Sheu BS. Intravenous proton pump inhibitors for peptic ulcer bleeding: Clinical benefits and limits. World J Gastrointest Endosc 2011, 3:49-56. 3066645, 21455342.
34. Cheung J, Yu A, LaBossiere J. Peptic ulcer bleeding outcomes adversely affected by end-stage renal disease. Gastrointest Endosc 2010, 71:44-49. 10.1016/j.gie.2009.04.014, 19595311.
35. Sabovic M, Lavre J, Vujkovac B. Tranexamic acid is beneficial as adjunctive therapy in treating major upper gastrointestinal bleeding in dialysis patients. Nephrol Dial Transplant 2003, 18:1388-1391. 10.1093/ndt/gfg117, 12808178.
36. Sreedhara R, Itagaki I, Lynn B, Hakim RM. Defective platelet aggregation in uremia is transiently worsened by hemodialysis. Am J Kidney Dis 1995, 25:555-563. 10.1016/0272-6386(95)90123-X, 7702050.
37. Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Health Technol Assess 2007, 11:1-164.
38. Barkun AN, Adam V, Sung JJ, Kuipers EJ, Mössner J, Jensen D, Stuart R, Lau JY, Nauclér E, Kilhamn J, Granstedt H, Liljas B, Lind T. Cost Effectiveness of High-Dose Intravenous Esomeprazole for Peptic Ulcer Bleeding. Pharmacoeconomics 2008, 28:217-230.